CTLA4 and ovarian carcinoma: Other studies also identify the increase of the lymphocyte infiltration and the T helper 1-type chemokines and cytokines as possible cause of the better observed outcome when de-methylation and anti-PD-L1 and CTLA4 agents are used in combination in a murine ovarian cancer model [188].